Component
Nitisinone
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
During nitisinone treatment in SONIA 2, urinary derivatives upstream of homogentisate increased and tracked treatment-associated hypertyrosinemia.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- AKU trial samples at baseline, 24 and 48 months; 47 treated serum and 53 treated urine sample series, with untreated comparisons.
- limitations
- Metabolite associations do not identify every conjugating enzyme or prove the proposed clearance benefit. This exposure is pharmacological.
- nutrient_topic
- L-Tyrosine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Tyrosine
- plain_language
- Blocking one step changes the distribution of metabolites across other routes.
- primary_references
- Comprehensive Biotransformation Analysis of Phenylalanine-Tyrosine Metabolism Reveals Alternative Routes of Metabolite Clearance in Nitisinone-Treated Alkaptonuria. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36295829/ · DOI 10.3390/metabo12100927
- trigger_kind
- biomarker_context Imported condition classification; unverified.
L-Tyrosine: catecholamines, thyroid chemistry, pigment, metabolism and cross-nutrient mechanisms (2026-09-19) · lines 308–314
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · AKU trial samples at baseline, 24 and 48 months; 47 treated serum and 53 treated urine sample series, with untreated comparisons. · source_derived_draft · unverified_draft
## l-tyrosine-nitisinone-network Blocking one step changes the distribution of metabolites across other routes. During nitisinone treatment in SONIA 2, urinary derivatives upstream of homogentisate increased and tracked treatment-associated hypertyrosinemia. Model: AKU trial samples at baseline, 24 and 48 months; 47 treated serum and 53 treated urine sample series, with untreated comparisons. Limitations: Metabolite associations do not identify every conjugating enzyme or prove the proposed clearance benefit. This exposure is pharmacological. Evidence access: Primary abstract Comprehensive Biotransformation Analysis of Phenylalanine-Tyrosine Metabolism Reveals Alternative Routes of Metabolite Clearance in Nitisinone-Treated Alkaptonuria. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36295829/ · DOI 10.3390/metabo12100927
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.